跳至主要內容

藥物交互作用

Bazedoxifene-conjugated estrogens + Lonapegsomatropin

嚴重程度: 中度

Bazedoxifene-conjugated estrogens and Lonapegsomatropin: moderate interaction.

最後更新

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

摘要

Oral estrogens reduce the hepatic production of IGF-1 in response to growth hormone, so the biological effect of lonapegsomatropin may be blunted. Patients may need a higher growth hormone dose to reach their IGF-1 target.

用白話說明這項交互作用的意義

Bazedoxifene-conjugated estrogens and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Bazedoxifene-conjugated estrogens belongs to Endocrine; Lonapegsomatropin belongs to Endocrine.

證據等級: Moderate

為什麼會發生

Oral estrogen exposure of the liver suppresses growth hormone-induced IGF-1 generation, causing partial growth hormone resistance.

處置方式

Monitor serum IGF-1 and clinical response when starting or stopping the estrogen-containing product, and titrate lonapegsomatropin dose accordingly.

可向藥師詢問的問題

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可解鎖 Bazedoxifene-conjugated estrogens 與 Lonapegsomatropin 的完整臨床處置建議、補充說明、證據詳情及整張處方的交互作用檢查工具。

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

在網頁版免費試用 Pro+ 14 天,無需信用卡。

常見問題

Can I take Bazedoxifene-conjugated estrogens with Lonapegsomatropin?

MediHelp rates the interaction as moderate. Bazedoxifene-conjugated estrogens and Lonapegsomatropin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Oral estrogens reduce the hepatic production of IGF-1 in response to growth hormone, so the biological effect of lonapegsomatropin may be blunted. Patients may need a higher growth hormone dose to reach their IGF-1 target.

How serious is the interaction between Bazedoxifene-conjugated estrogens and Lonapegsomatropin?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum IGF-1 and clinical response when starting or stopping the estrogen-containing product, and titrate lonapegsomatropin dose accordingly.

What other medicines interact with Bazedoxifene-conjugated estrogens?

MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥物交互作用

取得 App 登入